Application of knockout mouse models to investigate the influence of FcγR on the pharmacokinetics and anti-platelet effects of MWReg30, a monoclonal anti-GPIIb antibody-Reference-Cited by-同舟云学术

Application of knockout mouse models to investigate the influence of FcγR on the pharmacokinetics and anti-platelet effects of MWReg30, a monoclonal anti-GPIIb antibody

Published:2013-02 Issue:1-2 Volume:444 Page:185-192
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Abuqayyas Lubna,Zhang Xiaoyan,Balthasar Joseph P.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference34 articles.

1. Application of knockout mouse models to investigate the influence of FcR on the tissue distribution and elimination of 8C2, a murine IgG1 monoclonal antibody;Abuqayyas;Int. J. Pharmaceut.,2012

2. Fc receptor signaling and trafficking: a connection for antigen processing;Amigorena;Immunol. Rev.,1999

3. Fc receptors for IgG and antigen presentation on MHC class I and class II molecules;Amigorena;Semin. Immunol.,1999

4. GPIIb (CD41) integrin is expressed on mast cells and influences their adhesion properties;Berlanga;Exp. Hematol.,2005

5. Differential distribution of Fc gamma RIIIa in normal human tissues and co-localization with DAF and fibrillin-1: implications for immunological microenvironments;Bhatia;Immunology,1998

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors;Clinical Cancer Research;2023-12-13

2. FcγR-Mediated Trogocytosis 2.0: Revisiting History Gives Rise to a Unifying Hypothesis;Antibodies;2022-07-05

3. The Contribution of Liver Sinusoidal Endothelial Cells to Clearance of Therapeutic Antibody;Frontiers in Physiology;2022-01-14

4. Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective;Antibodies;2021-07-26

5. Principles of N-Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations;Antibodies;2020-06-10